Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

BZLFY or MDLZ: Which Is the Better Value Stock Right Now?
BZLFY or MDLZ: Which Is the Better Value Stock Right Now?

Investors interested in Food - Miscellaneous stocks are likely familiar with Bunzl PLC (BZLFY) and Mondelez (MDLZ). But which of these two stocks offers value investors a better bang for their buck

EVTC vs. RBA: Which Stock Should Value Investors Buy Now?
EVTC vs. RBA: Which Stock Should Value Investors Buy Now?

Investors with an interest in Financial Transaction Services stocks have likely encountered both Evertec (EVTC) and RB Global (RBA). But which of these two stocks presents investors with the better

GLDD or DY: Which Is the Better Value Stock Right Now?
GLDD or DY: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Building Products - Heavy Construction sector might want to consider either Great Lakes Dredge & Dock (GLDD) or Dycom Industries (DY). But which of these two

ASB or UMBF: Which Is the Better Value Stock Right Now?
ASB or UMBF: Which Is the Better Value Stock Right Now?

Investors interested in Banks - Midwest stocks are likely familiar with Associated Banc-Corp (ASB) and UMB Financial (UMBF). But which of these two stocks offers value investors a better bang for

SHG vs. NABZY: Which Stock Should Value Investors Buy Now?
SHG vs. NABZY: Which Stock Should Value Investors Buy Now?

Investors interested in stocks from the Banks - Foreign sector have probably already heard of Shinhan Financial (SHG) and National Australia Bank Ltd. (NABZY). But which of these two companies is

Implied Volatility Surging for Pure Storage Stock Options
Implied Volatility Surging for Pure Storage Stock Options

Investors in Pure Storage, Inc. PSTG need to pay close attention to the stock based on moves in the options market lately. That is because the Sept 19, 2025 $80.00 Put had some of the highest

Do Options Traders Know Something About TPG RE Finance Trust Stock We Don't?
Do Options Traders Know Something About TPG RE Finance Trust Stock We Don't?

Investors in TPG RE Finance Trust, Inc. TRTX need to pay close attention to the stock based on moves in the options market lately. That is because the Sept 19, 2025 $06.00 Put had some of the

Bear of the Day: Baidu (BIDU)
Bear of the Day: Baidu (BIDU)

Baidu (BIDU) reported their June quarter last Wednesday and delivered an earnings beat of 9% vs the Zacks Consensus. But a top-line revenue shortfall was a key disappointment for analysts and

AXIL Stock Falls After Posting FY25 Results Despite Y/Y EBITDA Growth
AXIL Stock Falls After Posting FY25 Results Despite Y/Y EBITDA Growth

Shares of AXIL Brands, Inc. AXIL have declined 5.2% since reporting results for the fourth quarter of fiscal 2025. This compares with the S&P 500 index’s 0.4% fall over the same time frame. Over the

JSDA Posts Q2 Profit From Cannabis Sale Despite Y/Y Revenue Dip
JSDA Posts Q2 Profit From Cannabis Sale Despite Y/Y Revenue Dip

Shares of Jones Soda Co. JSDA have declined 4.7% since reporting results for the second quarter of 2025. This compares with the S&P 500 index’s 1.3% growth over the same time frame. Over the past

Fortinet Expands Share Buyback Program by $1B: Buy Now or Hold?
Fortinet Expands Share Buyback Program by $1B: Buy Now or Hold?

Fortinet FTNT expanded its share repurchase program by $1 billion on Aug. 21, 2025, bringing the total authorized amount to $9.25 billion and extending the program through Feb. 28, 2027. With

ScanSource Q4 Earnings Surpass Estimates, Revenues Increase Y/Y
ScanSource Q4 Earnings Surpass Estimates, Revenues Increase Y/Y

ScanSource, Inc. SCSC reported adjusted earnings of $1.02 per share in fourth-quarter fiscal 2025 (ended June 30, 2025), beating the Zacks Consensus Estimate of 91 cents. The bottom line improved

Will Ford Pro's Market Share Gains in the US and Europe Continue?
Will Ford Pro's Market Share Gains in the US and Europe Continue?

Ford Motor Company’s F commercial fleet solutions provider unit, Ford Pro, stood out as the company’s primary growth engine in the second quarter. Over the past year, the segment has transformed by

Hormel Foods Readies for Q3 Earnings: What's in the Offing?
Hormel Foods Readies for Q3 Earnings: What's in the Offing?

Hormel Foods Corporation (HRL) is likely to register top-line growth when it reports third-quarter fiscal 2025 earnings on Aug. 28, before market open. The Zacks Consensus Estimate for quarterly

Franco-Nevada Stock Hits 52-Week High: What's Aiding Its Performance?
Franco-Nevada Stock Hits 52-Week High: What's Aiding Its Performance?

Franco-Nevada Corporation FNV shares scaled a new 52-week high of $186.12 on Friday before closing the session lower at $185.10. The increase was fueled by rising gold prices and the company’s solid

Can Carvana Deliver 40% CAGR in Unit Sales Over the Next 5 Years?
Can Carvana Deliver 40% CAGR in Unit Sales Over the Next 5 Years?

Carvana Co. CVNA is focusing on several key operational areas to achieve its goal of 40% compound annual growth in unit sales over the next five years. Reconditioning, which is considered the most

NVTS Targets AI Data Centers: Can it Capitalize on the 800-Volt Shift?
NVTS Targets AI Data Centers: Can it Capitalize on the 800-Volt Shift?

Navitas Semiconductor (NVTS) is shifting its focus to AI data centers as power needs are rising fast. AI processors are utilizing much more power than traditional systems. Additionally, industry

Home Depot Q2 EPS Stays Flat: Are Margins the Next Risk Factor?
Home Depot Q2 EPS Stays Flat: Are Margins the Next Risk Factor?

The Home Depot, Inc.’s HD second-quarter fiscal 2025 results show that while earnings per share held steady, margin pressure remains a key issue. The company reported earnings of $4.58, marginally

Ubiquiti Q4 Earnings Surpass Estimates, Top Line Surges Y/Y
Ubiquiti Q4 Earnings Surpass Estimates, Top Line Surges Y/Y

Ubiquiti, Inc. UI reported strong fourth-quarter fiscal 2025 results, with both bottom and top lines surpassing the respective Zacks Consensus Estimates. The New York-based networking products and

Brown-Forman Q1 Earnings: Will Brand Strength Outweigh Margin Woes?
Brown-Forman Q1 Earnings: Will Brand Strength Outweigh Margin Woes?

Brown-Forman Corporation (BF.B) is slated to release first-quarter fiscal 2026 results on Aug. 28. The alcoholic beverage bigwig’s revenues and earnings per share are expected to decline year over

Bumble's Customer Retention Rate Slips: Is Growth Getting Harder?
Bumble's Customer Retention Rate Slips: Is Growth Getting Harder?

Bumble BMBL shares tumbled 8% in after-hours trading following second-quarter 2025 earnings that revealed deepening customer retention challenges, with paying users declining 8.7% to 3.8 million

Abercrombie's Sales Trends Positive Pre-Q2 Earnings: Can It Surprise?
Abercrombie's Sales Trends Positive Pre-Q2 Earnings: Can It Surprise?

Abercrombie & Fitch Co. ANF is scheduled to report second-quarter fiscal 2025 results on Aug. 27, before the opening bell. The Zacks Consensus Estimate for ANF’s fiscal second-quarter revenues is

Here's How Costco's Digital Shift Is Emerging as Key Growth Driver
Here's How Costco's Digital Shift Is Emerging as Key Growth Driver

Costco Wholesale Corporation COST reported strong third-quarter fiscal 2025 results, with digital commerce emerging as a key growth engine. Net sales increased 8% year over year to $62 billion. In

Top 5 ETFs and Stocks to Watch as the Fed Eyes Rate Cuts
Top 5 ETFs and Stocks to Watch as the Fed Eyes Rate Cuts

For much of the past two years, U.S. markets have been dominated by a higher-for-longer rate regime. Growth stocks, particularly the tech-heavy Magnificent Seven, have thrived in this environment

PGEN Stock Surges 144% in August on FDA Nod for Rare Lung Disease Drug
PGEN Stock Surges 144% in August on FDA Nod for Rare Lung Disease Drug

Shares of Precigen, Inc. PGEN have skyrocketed 144.4% in August so far, following the company's announcement of the FDA approval for Papzimeos (zopapogene imadenovec-drba) for the treatment of